Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE -- Ignore unavailable to you. Want to Upgrade?

To: HB who wrote (175)	12/20/1998 9:56:00 PM
From: John O'Neill	Respond to of 415

I tripled my position at $3.75.... It looks like the cyclosporin with J&J is going well....The 2 week trial was very promising, IMHO. The 4 week trial may have been delayed due to contamination of the product after the first large scale production run intended for use in the 4 week trial....I think they are making another batch while also trying to filter out the impurity (which came in after the production). I hope to see the J&J $2mil milestone payment come in early summer with first human trial in Europe. That may spark the stock.....maybe a January effect will help too